C
688065
vs
S
Shanghai Composite
Over the past 12 months, Cathay Biotech Inc has underperformed Shanghai Composite, delivering a return of +15% compared to the Shanghai Composite's +24% growth.
Stocks Performance
688065 vs Shanghai Composite
Performance Gap
688065 vs Shanghai Composite
Performance By Year
688065 vs Shanghai Composite
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Cathay Biotech Inc
Glance View
Cathay Biotech Inc. emerged from China's bustling metropolis of Shanghai, carving a niche in the realm of synthetic biology. Born in the late 1990s, the company set its sights on transforming the industrial landscape by harnessing the power of biomanufacturing. Cathay positioned itself as a leader in the production of long-chain diacid (LCDA) and bio-based polyamides, which are integral to a wide array of industries, including automotive, consumer electronics, and textiles. The company's core technology lies in advanced fermentation processes, where microorganisms are bioprocessed to produce these high-performance materials. These procedures not only reduce dependency on petrochemicals but also showcase the potential for sustainable innovations in industrial applications. Cathay Biotech monetizes its expertise by serving as a vital supplier for manufacturers worldwide, tapping into its patented technologies and scaling them to meet commercial demands. Its commitment to R&D has not only propelled the firm’s growth but also established long-term partnerships with key players across various sectors. Through its production facilities, Cathay has managed to fine-tune its microorganism strains and fermentation processes, leading to increased efficiencies and cost-effectiveness. This symbiotic relationship between innovation and commercialization at Cathay Biotech has allowed it to create a robust business model, drawing significant revenue from the sale of its bio-based products while consistently investing in technological advancements to expand its product portfolio.
